Although nanotechnology has enhanced cancer treatment, the use of nanomaterials in this technology may exhibit cytotoxicity ( 8.4 Small molecules inducing ferroptosis Resistance to radiotherapy and chemotherapy can lead to treatment failure, making Ferroptosis a new target for traditional treatment ( Table 2
In fulfilllling this protective role, reduced glutathione is converted into oxidized glutathione, at which point it becomes inactive
Again, these toxins are designed to inhibit the growth of a competing colony
Tirzepatide has a half-life of approximately 5 days, allowing for once-weekly dosing
Park W, Wei S, Kim B-S, Kim B, Bae S-J, Chae YC, et al